BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29113667)

  • 1. ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis.
    Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Expósito-Ruiz M; Calleja-Hernández MÁ
    Surg Oncol; 2017 Dec; 26(4):473-482. PubMed ID: 29113667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.
    Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Segura-Pérez AM; Chamorro-Santos C; Vergara-Alcaide E; Castillo-Portellano L; Calleja-Hernández MÁ
    Pharmacol Res; 2016 Jun; 108():111-118. PubMed ID: 27137881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
    Priyadarshini R; Raj GM; Kayal S; Ramesh A; Shewade DG
    J Clin Pharm Ther; 2019 Apr; 44(2):188-196. PubMed ID: 30637776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes.
    Wu H; Kang H; Liu Y; Tong W; Liu D; Yang X; Lian M; Yao W; Zhao H; Huang D; Sha X; Wang E; Wei M
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1449-62. PubMed ID: 22526155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of (C1236T and C3435T) Polymorphisms of ABCB1 Gene on Chemotherapy Treatment Outcome and Toxicity in Breast Cancer Patients.
    Gudur RA; Bhosale SJ; Gudur AK; Kale SR; More AL; Datkhile KD
    Asian Pac J Cancer Prev; 2024 May; 25(5):1567-1577. PubMed ID: 38809628
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chouchi M; Klaa H; Ben-Youssef Turki I; Hila L
    Dis Markers; 2019; 2019():1343650. PubMed ID: 31871496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.
    Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Cufer T
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1551-60. PubMed ID: 22543673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB1 Polymorphisms and Childhood Acute Lymphoblastic Leukemia Risk: A Meta-Analysis.
    Zhan L; Lian J; Jin H; Wang S; Ding J; Shao Z
    Crit Rev Eukaryot Gene Expr; 2017; 27(2):173-181. PubMed ID: 28845766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis.
    Tazzite A; Kassogue Y; Diakité B; Jouhadi H; Dehbi H; Benider A; Nadifi S
    BMC Genet; 2016 Sep; 17(1):126. PubMed ID: 27580695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of three ABCB1 (MDR1) gene variants (C1236T, G2677A/T and C3435T) and their genotype/haplotype combinations with the familial Mediterranean fever.
    Rustemoglu A; Gumus-Akay G; Karakus N; Yigit S; Sahin S; Tasliyurt T
    Xenobiotica; 2014 Oct; 44(10):933-40. PubMed ID: 24773260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
    Johnatty SE; Beesley J; Gao B; Chen X; Lu Y; Law MH; Henderson MJ; Russell AJ; Hedditch EL; Emmanuel C; Fereday S; Webb PM; ; Goode EL; Vierkant RA; Fridley BL; Cunningham JM; Fasching PA; Beckmann MW; Ekici AB; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Brown R; Paul J; Lambrechts S; Despierre E; Vergote I; Lester J; Karlan BY; Heitz F; du Bois A; Harter P; Schwaab I; Bean Y; Pejovic T; Levine DA; Goodman MT; Camey ME; Thompson PJ; Lurie G; Shildkraut J; Berchuck A; Terry KL; Cramer DW; Norris MD; Haber M; MacGregor S; deFazio A; Chenevix-Trench G
    Gynecol Oncol; 2013 Oct; 131(1):8-14. PubMed ID: 23917080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
    Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of
    Shao S; Hu L; Han Z; Hou K; Fang H; Zhang G; Feng Y; Huang L
    Transl Androl Urol; 2020 Apr; 9(2):673-683. PubMed ID: 32420174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ABCB1 Polymorphism on Levetiracetam Serum Concentrations in Epileptic Uygur Children in China.
    Zhao T; Yu J; Wang TT; Feng J; Zhao WB; Sun L; Yu LH; Li HJ; Sun Y
    Ther Drug Monit; 2020 Dec; 42(6):886-892. PubMed ID: 32890316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene.
    van Assema DM; Lubberink M; Rizzu P; van Swieten JC; Schuit RC; Eriksson J; Scheltens P; Koepp M; Lammertsma AA; van Berckel BN
    EJNMMI Res; 2012 Oct; 2(1):57. PubMed ID: 23067778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
    Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Biswas NR; Gupta YK
    Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.
    Kim HJ; Im SA; Keam B; Ham HS; Lee KH; Kim TY; Kim YJ; Oh DY; Kim JH; Han W; Jang IJ; Kim TY; Park IA; Noh DY
    Cancer Sci; 2015 Jan; 106(1):86-93. PubMed ID: 25410489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.
    Ben Hassine I; Gharbi H; Soltani I; Ben Hadj Othman H; Farrah A; Amouri H; Teber M; Ghedira H; Ben Youssef Y; Safra I; Abbes S; Menif S
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):829-839. PubMed ID: 28836054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients.
    Turiján-Espinoza E; Ruíz-Rodríguez VM; Uresti-Rivera EE; Martínez-Leija E; Zermeño-Nava JJ; Guel-Pañola A; Romano-Moreno S; Vargas-Morales JM; Portales-Pérez DP
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):843-853. PubMed ID: 33740100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo-adjuvant chemotherapy.
    Priyadarshini R; Raj GM; Sundaram R; Kayal S; Ramesh A; Shewade DG
    Breast Cancer; 2021 Mar; 28(2):414-423. PubMed ID: 33125673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.